4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-008780
CEO sold 23,100 shares at an average $103.02 ($2,379,779)
- CEO acquired 23,100 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Zovighian Bernard J · CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +23,100 | $72.68 | $1,678,908 | 121,945 | D |
| 2026-11-09 | Sale : show line 2 in the form 10b5-1 | −9,184 | $103.39 | $949,489 | 112,761 | D |
| 2026-11-09 | Sale : show line 3 in the form 10b5-1 | −13,916 | $102.78 | $1,430,291 | 98,845 | D |
| Open-market sales · 23,100 sh · avg $103.02 · $2,379,779 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-09 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −23,100 | 23,100 | D |
Loading xslF345X06/doc4.xml…